{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:18:16Z","timestamp":1776979096622,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jhlto.2025.100467","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:06:53Z","timestamp":1765526813000},"page":"100467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Medium-term comprehensive outcomes of heart transplantation using donors with hepatitis C viremia to aviremic recipients"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9875-6849","authenticated-orcid":false,"given":"Ritika","family":"Mazumder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4830-9176","authenticated-orcid":false,"given":"Sarah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9287-3180","authenticated-orcid":false,"given":"Sakthi Surya","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3874-1399","authenticated-orcid":false,"given":"Qijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3207-2231","authenticated-orcid":false,"given":"Omar T.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-4860","authenticated-orcid":false,"given":"Randall C.","family":"Starling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-3748","authenticated-orcid":false,"given":"William","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2025.100467_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008764","article-title":"Changing demographics, temporal trends in waitlist, and posttransplant outcomes after heart transplantation in the United States: analysis of the UNOS database 1991-2019","volume":"14","author":"Akintoye","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhlto.2025.100467_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14181","article-title":"Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality","volume":"35","author":"Stern","year":"2021","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib3","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/ajt.13971","article-title":"Improving organ utilization to help overcome the tragedies of the opioid epidemic","volume":"16","author":"Goldberg","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.29572","article-title":"The rise of the opioid epidemic and hepatitis C-positive organs: a new era in liver transplantation","volume":"67","author":"Gonzalez","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhlto.2025.100467_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2019.4748","article-title":"Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C","volume":"5","author":"Schlendorf","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jhlto.2025.100467_bib6","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients","volume":"296","author":"Gasink","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jhlto.2025.100467_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1053-2498(03)00148-7","article-title":"Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation","volume":"23","author":"Haji","year":"2004","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib8","first-page":"85","article-title":"Hepatitis C virus treatment and solid organ transplantation","volume":"18","author":"Patnaik","year":"2022","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jhlto.2025.100467_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cardfail.2021.07.007","article-title":"HCV-positive allograft use in heart transplantation is associated with increased access to overdose donors and reduced waitlist mortality without compromising outcomes","volume":"28","author":"Altshuler","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100467_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","article-title":"Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies","volume":"37","author":"Schlendorf","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib11","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100467_bib12","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1111\/ajt.15311","article-title":"Transplanting hepatitis C virus-infected hearts into uninfected recipients: a single-arm trial","volume":"19","author":"McLean","year":"2019","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014495","article-title":"Outcomes of adult heart transplantation using hepatitis C-positive donors","volume":"9","author":"Kilic","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jhlto.2025.100467_bib14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5500\/wjt.v12.i12.394","article-title":"Review of heart transplantation from hepatitis C-positive donors","volume":"12","author":"Patel","year":"2022","journal-title":"World J Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/imj.12936","article-title":"The association between chronic hepatitis C infection and cardiovascular risk","volume":"46","author":"Pateria","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.jhlto.2025.100467_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/hrt.2003.018937","article-title":"Evidence for association between hepatitis C virus seropositivity and coronary artery disease","volume":"90","author":"Vassalle","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jhlto.2025.100467_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/599371","article-title":"Hepatitis C virus infection and the risk of coronary disease","volume":"49","author":"Butt","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2025.100467_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.xjon.2022.10.007","article-title":"Trends and three-year outcomes of hepatitis C virus-viremic donor heart transplant for hepatitis C virus-seronegative recipients","volume":"12","author":"Ruck","year":"2022","journal-title":"JTCVS Open"},{"key":"10.1016\/j.jhlto.2025.100467_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.athoracsur.2022.11.002","article-title":"Outcomes of over 1000 heart transplants using hepatitis C-positive donors in the modern era","volume":"115","author":"Kwon","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jhlto.2025.100467_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40472-021-00350-1","article-title":"Hepatitis C positive organ donation in heart transplantation","volume":"8","author":"Siddiqi","year":"2021","journal-title":"Curr Transpl\u00a0Rep"},{"key":"10.1016\/j.jhlto.2025.100467_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.healun.2019.06.023","article-title":"Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era","volume":"38","author":"Madan","year":"2019","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.healun.2014.02.027","article-title":"Report from a consensus conference on primary graft dysfunction after cardiac transplantation","volume":"33","author":"Kobashigawa","year":"2014","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010 [published correction appears in J Heart Lung Transplant. 2011 Mar;30(3):360]","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.healun.2023.12.012","article-title":"Racial and gender disparities in transplantation of hepatitis C+ hearts and lungs","volume":"43","author":"Hannan","year":"2024","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cld.2006.08.025","article-title":"Hepatitis C in transplant recipients of solid organs, other than liver","volume":"10","author":"Wells","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhlto.2025.100467_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15325","article-title":"Hepatitis C viremic lung transplantation to aviremic recipients: comprehensive outcomes and post-transplant viremia","volume":"38","author":"Khan","year":"2024","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/lt.25925","article-title":"Liver transplantation using hepatitis C virus-viremic donors into hepatitis C virus-aviremic recipients as standard of care","volume":"27","author":"Bohorquez","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15294","article-title":"Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors","volume":"38","author":"Kadosh","year":"2024","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib30","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1111\/ajt.17190","article-title":"Long-term follow-up of acute and chronic rejection in heart transplant recipients from hepatitis C viremic (NAT+) donors","volume":"22","author":"Stachel","year":"2022","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2023.09.015","article-title":"Early assessment of cardiac allograft vasculopathy risk among recipients of hepatitis C virus-infected donors in the current era","volume":"30","author":"Amancherla","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.jhlto.2025.100467_bib32","unstructured":"American Association for the Study of Liver Disease. Treatment of HCV-uninfected transplant recipients receiving organs from HCV-viremic donors. 2022 Oct 24, 2022 Dec 13, 2022.\u00a0Available at:\u00a0https:\/\/www.hcvguidelines.org\/unique-populations\/organs-from-hcv-viremic-donors."},{"key":"10.1016\/j.jhlto.2025.100467_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1053-2498(98)00019-9","article-title":"Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: Is azathioprine a contributory factor?","volume":"18","author":"Delgado","year":"1999","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ajt.15664","article-title":"Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients","volume":"20","author":"Gupta","year":"2020","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhlto.2025.100467_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cld.2022.01.012","article-title":"The use of hepatitis C virus-positive organs in hepatitis C virus-negative recipients","volume":"26","author":"Kuntzen","year":"2022","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhlto.2025.100467_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2468-1253(20)30081-9","article-title":"Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study [published correction appears in Lancet Gastroenterol Hepatol. 2020 Jul;5(7):e6]","volume":"5","author":"Feld","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhlto.2025.100467_bib37","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2468-1253(19)30240-7","article-title":"Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study","volume":"4","author":"Bethea","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhlto.2025.100467_bib38","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.healun.2020.06.022","article-title":"Increased early acute cellular rejection events in hepatitis C-positive heart transplantation","volume":"39","author":"Gidea","year":"2020","journal-title":"J Heart Lung Transpl"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425002666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425002666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:29:39Z","timestamp":1776976179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133425002666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"alternative-id":["S2950133425002666"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100467","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medium-term comprehensive outcomes of heart transplantation using donors with hepatitis C viremia to aviremic recipients","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100467"}}